Skip to content
Brain & Nerves — NMDA receptor antagonistsATC N06DX01

Memantine

Prescription only

Alzheimer's medicine for moderate to severe stages.

Starts working
Varies
Half-life
60–100 hours
In use since
2003
Pregnancy
Use with caution

Overview

Memantine can modestly help thinking, daily function and agitation in moderate to severe Alzheimer's disease. It's often combined with donepezil and is generally well tolerated.

Conditions it's used for

How it works

Protects brain cells from too much stimulation.

Memantine belongs to the NMDA receptor antagonists. How NMDA receptor antagonists work: shield brain cells from too much glutamate signalling.

Uses

  • Moderate to severe Alzheimer's disease

Available as: tablet, oral solution, capsule.

Typical dose

Adults
5 mg a day, increased weekly to 20 mg a day.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Dizziness
  • Headache
  • Constipation
  • Sleepiness

Serious — get medical help

Uncommon, but need prompt attention

  • Confusion or hallucinations (rare)
  • Seizures (rare)

Warnings

  • Lower dose in kidney disease

Interactions

  • Amantadine, ketamine, dextromethorphan — similar effects
Check Memantine against your own medicines

Pregnancy and breastfeeding

Use with caution

No data.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Namenda, Namzaric (with donepezil)
United Kingdom
Ebixa
India
Admenta, Mentadem
Australia
Ebixa

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Can it be combined with donepezil?

Yes, they work differently and are often used together.

Do I need a prescription for Memantine?

Yes — Memantine is prescription-only in most countries.

Can I take Memantine during pregnancy?

Use with caution. No data. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.